Literature DB >> 14522724

The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002.

Pierre Bourlioux1, Berthold Koletzko, Francisco Guarner, Véronique Braesco.   

Abstract

The intestine is an extremely complex living system that participates in the protection of the host through a strong defense against aggressions from the external environment. This defensive task is based on 3 constituents that are in permanent contact and dialog with each other: the microflora, mucosal barrier, and local immune system. We review herein current knowledge about these important functions. The gut microflora play a major role against exogenous bacteria through colonization resistance, but the mechanism of action is not yet established, although it is linked to the bacteria colonizing the gut. This colonization involves bacteria-bacteria dialog, bacteria-mucins interactions, and bacteria-colonocytes cross-talk associated with environmental factors. The intestinal mucosa is a cellular barrier and the main site of interaction with foreign substances and exogenous microorganisms. It is a complex physicochemical structure consisting of a mucous layer linked to cellular and stromal components that participate in the defense of the host through mucosal blood flow, mucosal secretions, epithelial cell functionals, surface hydrophobicity, and defensin production. The intestine is the primary immune organ of the body represented by the gut-associated lymphoid tissue through innate and acquired immunity. This immune system can tolerate dietary antigens and the gut-colonizing bacteria and recognizes and rejects enteropathogenic microorganisms that may challenge the body's defenses. In cooperation with these endogenous barriers, some in-transit bacteria, such as probiotics, can act as partners of the defense system of the intestine.

Entities:  

Mesh:

Year:  2003        PMID: 14522724     DOI: 10.1093/ajcn/78.4.675

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  62 in total

1.  Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model.

Authors:  Faping Duan; John C March
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Fate of dietary phytosteryl/-stanyl esters: analysis of individual intact esters in human feces.

Authors:  Tim Lubinus; Andreas Barnsteiner; Thomas Skurk; Hans Hauner; Karl-Heinz Engel
Journal:  Eur J Nutr       Date:  2012-07-10       Impact factor: 5.614

Review 3.  Toward improving mucosal barrier defenses: rhG-CSF plus IgG antibody.

Authors:  Aryeh Simmonds; Edmund F LaGamma
Journal:  Indian J Pediatr       Date:  2006-11       Impact factor: 1.967

Review 4.  Addressing the "New" NEC: Part I: rediscovering the basics.

Authors:  Aryeh Simmonds; Edmund F LaGamma
Journal:  Indian J Pediatr       Date:  2006-11       Impact factor: 1.967

Review 5.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

6.  Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation.

Authors:  Patricia W Lin; Loren E S Myers; Laurie Ray; Shuh-Chyung Song; Tala R Nasr; Andrew J Berardinelli; Kousik Kundu; Niren Murthy; Jason M Hansen; Andrew S Neish
Journal:  Free Radic Biol Med       Date:  2009-08-03       Impact factor: 7.376

7.  Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses.

Authors:  Brett M Jakaitis; Patricia W Denning
Journal:  Pathophysiology       Date:  2014-01-17

Review 8.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

Review 9.  The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.

Authors:  Michel J van Vliet; Hermie J M Harmsen; Eveline S J M de Bont; Wim J E Tissing
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

10.  Different roles for lactococcal aggregation factor and mucin binding protein in adhesion to gastrointestinal mucosa.

Authors:  Jovanka Lukić; Ivana Strahinić; Branko Jovčić; Brankica Filipić; Ljubiša Topisirović; Milan Kojić; Jelena Begović
Journal:  Appl Environ Microbiol       Date:  2012-09-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.